Related Experiment Video
Updated: Apr 23, 2026
07:38
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
941
Phenotypes associated with inherited and developmental somatic mutations in genes encoding mTOR pathway components.
Anurag Saxena1, Julian R Sampson1
1Institute of Medical Genetics, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, UK.
Seminars in Cell & Developmental Biology
|September 30, 2014
Summary
Rare inherited disorders linked to the mammalian target of rapamycin (mTOR) pathway mutations cause tumors and developmental issues. Inhibiting mTOR complex 1 (mTORC1) shows promise for treating these conditions.
Area of Science:
- Genetics
- Developmental Biology
- Pharmacology
Background:
- Mutations in genes encoding upstream components of the mammalian target of rapamycin (mTOR) pathway cause rare inherited and developmental disorders.
- These disorders share overlapping clinical features, including tumor predisposition, localized overgrowth, and brain abnormalities.
Purpose of the Study:
- To review inherited and developmental disorders associated with mTOR pathway mutations.
- To discuss recent therapeutic advancements using mTOR complex 1 (mTORC1) inhibition.
Main Methods:
- Literature review of genetic disorders affecting the mTOR pathway.
- Analysis of clinical features and therapeutic strategies involving mTORC1 inhibitors.
Main Results:
- Hyperactivation of mTORC1 signaling is implicated in the pathogenesis of these disorders.
- Rapamycin and its derivatives are potential therapeutic agents.
Conclusions:
- mTORC1 inhibition represents a promising therapeutic avenue for rare inherited and developmental disorders.
- Further research into mTORC1-targeted therapies is warranted for these complex conditions.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
03:03mTOR Signaling and Cancer Progression
1.5K
1.5K
01:22PI3K/mTOR/AKT Signaling Pathway
5.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.1K
02:21Cancers Originate from Somatic Mutations in a Single Cell
12.2K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.2K
01:19Interactions Between Signaling Pathways
4.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.6K
01:33Cancer-Critical Genes I: Proto-oncogenes
8.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K